Ernexa Therapeutics Inc. ERNA
1.36 USD -0.27 (-16.56%)
Regular-session close
1.35 -0.01 -0.74%
After hours · Nov 20, 4:00 PM ET
1.35 Day range 1.60
1.36 52-week range 37.00
- YTD
- -95.47%
- 1 year
- -95.75%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -9.10M | -17.18M | -21.14M | -34.36M | -113.73M | |
| -14.08M | -44.54M | -21.67M | -24.58M | -122.55M | |
| -56.00 | -1,224.00 | -1,531.00 | -3,022.00 | -21,229.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.88M | 1.73M | 11.67M | 15.54M | 16.98M | |
| 5.83M | 5.27M | 49.13M | 22.28M | 31.52M | |
| 3.43M | 3.57M | 46.90M | 10.17M | 6.02M | |
| 490.00K | 684.00K | 41.84M | 1.18M | 2.72M | |
| 2.40M | 1.70M | 2.23M | 12.11M | 25.50M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -7.02M | -15.84M | -20.41M | -20.98M | -23.49M | |
| -37.00K | -365.00K | -19.00K | -47.00K | -22.74M | |
| 7.21M | 6.26M | 16.56M | 19.58M | 61.59M | |
| -37.00K | -365.00K | -19.00K | -47.00K | -154.00K | |
| 155.00K | -9.94M | -3.87M | -1.44M | 15.36M |
